Comparison of Bivalirudin versus heparin during
            percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to
            reduced clinical events [REPLACE]-1 trial)

Lincoff, A Michael; Bittl, John A; Kleiman, Neal S; Sarembock, Ian J; Jackman, J Daniel; Mehta, Sameer; Tannenbaum, Mark A; Niederman, Alan L; Bachinsky, William B; Tift-Mann, J; Parker, H Graham; Kereiakes, Dean J; Harrington, Robert A; Feit, Frederick; Maierson, Elizabeth S; Chew, Derek Peng; Topol, Eric J

Comparison of Bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to reduced clinical events [REPLACE]-1 trial)

Date

2004

Authors

Lincoff, A Michael

Bittl, John A

Kleiman, Neal S

Sarembock, Ian J

Jackman, J Daniel

Mehta, Sameer

Tannenbaum, Mark A

Niederman, Alan L

Bachinsky, William B

Tift-Mann, J

Show 7 more

Citation

Lincoff, A.M., Bittl, J.A., Kleiman, N.S., Sarembock, I.J., Jackman, J.D., Mehta, S., Tannenbaum, M.A., Niederman, A.L., Bachinsky, W.B., Tift-Mann, J., et al., 2004. Comparison of Bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI linking angiomax to reduced clinical events [REPLACE]-1 trial). American Journal of Cardiology, 93(9), 1092-1096.